Article citationsMore>>

Hauser, S.L., et al. (2017) Ocrelizumab versus Interferon Beta-la in Relapsing Multiple Sclerosis. The New England Journal of Medicine, 376, 221-234.
https://pubmed.ncbi.nlm.nih.gov/28002679/

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top